Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2

In conclusion, the studies promoting mAB therapy in COVID-19 are very promising but the results are not yet definitive and more investigations are needed to certify both their good neutralizing effects of SARS-CoV-2, and to eliminate, or at least mitigate, the harmful side effects.PMID:33904269 | DOI:10.23812/Conti_Edit_35_2_1

Source: Journal of Biological Regulators and Homeostatic Agents - April 27, 2021 Category: Biomedical Science Authors: P Conti F E Pregliasco V Calvisi V Calvisi Al Caraffa C E Gallenga S K Kritas G Ronconi Source Type: research